Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Steven Kafka, Christopher McGuigan

Premium

Foundation Medicine has appointed Steven Kafka to chief business officer, a newly created position. He joins the company from Aileron Therapeutics, where he served as chief operating officer and chief financial officer. Previously, he was vice president of finance for Infinity Pharmaceuticals and senior director of finance at Millennium Pharmaceuticals. He holds a BA from Stanford University and a PhD from Harvard University.


Christopher McGuigan has been appointed to serve on Trovagene's board of directors.

McGuigan has been head of medicinal chemistry at Cardiff University and a professor at the Welsh School of Pharmacy since 1995, and last year he was appointed pro vice chancellor at the school. He also is a member of the editorial board for the Journal of Molecular Pharmaceutics and a former president of the International Society for Antiviral Research.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.